Capecitabine

NDC 69097-949 · Cipla USA Inc.

Generic nameCapecitabine

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)CAPECITABINE

Strength150 mg/1

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

69097-949-03 — 60 TABLET, FILM COATED in 1 BOTTLE (69097-949-03)

J8522 — Capecitabine, oral, 50 mg Medicare Part B payment limit (ASP + 6%): $0.08

FDA lists these products with the same active ingredient.

61269-475 — capecitabine, 62756-238 — Capecitabine, 62756-239 — Capecitabine, 67877-458 — Capecitabine, 67877-459 — Capecitabine, 68001-487 — CAPECITABINE, 68001-488 — CAPECITABINE, 68001-643 — Capecitabine, 68001-644 — Capecitabine, 69097-948 — Capecitabine, 70756-815 — Capecitabine, 70756-816 — Capecitabine, 72205-006 — Capecitabine, 72205-007 — Capecitabine, 72485-204 — Capecitabine, 72485-205 — Capecitabine, 72603-303 — capecitabine, 82009-112 — Capecitabine, 82249-207 — Capecitabine, 82249-210 — Capecitabine, +15 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.